New Jersey Prostate Cancer Research Fund is sponsored by New Jersey Department of Health / New Jersey Commission on Cancer Research (NJCCR). The New Jersey Prostate Cancer Research Fund supports innovative research focusing on the causes, prevention, screening, treatment, and cure of prostate cancer. This includes basic, behavioral, clinical, demographic, epidemiological, and psychosocial research.

The New Jersey Cancer Research Fund is a grant from the New Jersey Commission on Cancer Research (NJCCR) that funds pre-doctoral and post-doctoral fellowships and cancer research projects at nonprofit research institutions in New Jersey. Pre-doctoral applicants must be full-time graduate students enrolled in a course of study directly related to cancer, with New Jersey residents given priority. Post-doctoral candidates must hold a Ph.D., M.D., Dr. P.H., D.O., or equivalent graduate degree and be accepted for postdoctoral training under an appropriate sponsor at a qualifying New Jersey institution. The program does not support very senior postdoctoral fellows or those pursuing second training fellowships. Funding amounts vary by fellowship type and research project scope.

NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.